Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by bealerton Nov 29, 2023 2:53pm
205 Views
Post# 35759322

Great Buy Out Opportunity to snag a 43 million write off.

Great Buy Out Opportunity to snag a 43 million write off.Mr. Biorun, I liked you last post and it would be a great windfall for anyone of substance taking over the whole company with that lucrative write off waiting in the wings.

The sad thing we have to face is that real people have had to dig up that 43 million first in order for it to be expended over the years.  Many of those people will never see a penny since they most likely have moved on long ago.  Even is we surviving shareholders could all sell our 253,000,000 issued shares today at 9 cents, we would still have a net deficit of 23 million dollars, which real people have lost real money.

Figures don't lie.

Have a great day and let's hope SBM will be a real SANTA this year.

BeAlert
<< Previous
Bullboard Posts
Next >>